Ozlem Ergun, Ph.D.
Professor, Mechanical and Industrial Engineering, Northeastern University College of Engineering
Dr. Özlem Ergun’s research focuses on the design and management of large-scale and decentralized networks. She has applied her work on network design, management, and resilience to problems arising in many critical systems including transportation, pharmaceuticals, and healthcare. She has worked with organizations that respond to emergencies and humanitarian crises around the world, including USAID, UNWFP, UNHCR, IFRC, OXFAM America, CARE USA, FEMA, USACE, CDC, AFCEMA, and MedShare International. Dr. Ergun contributes regularly to Auribus Consulting, a Boston-based management consulting firm, as a logistics and analytics expert. Dr. Ergun has also been a leader in establishing a strong community of OR/MS professionals with an interest in public programs. She was the President of INFORMS Section on Public Programs, Service and Needs in 2013. She currently serves as the Area Editor at the Operations Research journal for Policy Modeling and the Public Sector Area. Dr. Ergun is also a founding co-chair of the annual Health and Humanitarian Logistics Conference, held annually since 2009.
Erin Fox, Pharm.D.
Senior Director, Drug Information and Support Services, University of Utah Health
Erin R. Fox, PharmD, BCPS, FASHP, is senior pharmacy director of Drug Information and Support Services at University of Utah Health. Erin is also Associate Professor (Adjunct), at the Department of Pharmacotherapy, University of Utah College of Pharmacy. The University of Utah Drug Information Service provides content for the ASHP Drug Shortage Resource Center and Erin serves as a media resource and advocate for changes to improve the ongoing drug shortage situation and rising drug costs. Erin is also active in both state and national pharmacy and health-related societies serving in a variety of volunteer and elected positions. Erin is recognized as an expert in drug shortages and has received the ISMP Cheers Award and ASHP Award of Excellence in recognition for her work on drug shortages. Erin has also been honored with the William A. Zellmer Lecture award for her advocacy efforts to address drug shortages and rising drug prices.
Larry Glasscock, B.A.
Chief Operating Officer, NFH
Larry M. Glasscock is a businessperson who has been at the helm of and/or provided executive leadership for companies across a variety of segments. Presently, Mr. Glasscock holds the position of Chief Operating Officer of NFH, Inc. and serves in an executive advisory capacity for MNX Global Logistics. Mr. Glasscock serves on the Board of Kershaw’s Challenge, a public charity founded by Ellen and Clayton Kershaw and is a member of the Radiopharmaceutical Shippers and Carriers Conference. Mr. Glasscock has extensive experience in the development of unique, global supply chain solutions for healthcare and medical research companies of all types with specific leadership in nuclear medicine and immunotherapy. He is known to be particularly adept at forming partnerships and alliances for the benefit of manufacturers, researchers, treatment centers, and patients throughout the world.
Lewis Grossman, J.D.
Professor of Law, American University, Washington School of Law
Lewis Grossman is Professor of Law at the Washington College of Law, where he has taught since 1997 and where he served as Associate Dean for Scholarship from 2008 to 2011. He teaches and writes in the areas of food and drug law, health law, American legal history, and civil procedure. He has also been a Visiting Professor of Law at Cornell Law School and a Law and Public Affairs (LAPA) Fellow at Princeton University. Prior to joining the American University faculty, he was an associate at Covington & Burling LLP in Washington, D.C. Before that, he clerked for Chief Judge Abner Mikva of the U.S. Court of Appeals for the D.C. Circuit. Professor Grossman’s scholarship has appeared in the Cornell Law Review, Law and History Review, Yale Journal of Health Policy, Law & Ethics, and Administrative Law Review, among others. He has made recent contributions to volumes published by Oxford University Press and Columbia University Press. He is the co-author of Food and Drug Law: Cases and Materials (with Peter Barton Hutt and Richard A. Merrill) and of a widely used supplement to the first-year civil procedure course titled A Documentary Companion to A Civil Action (with Robert G. Vaughn). In 2021, Oxford University Press will publish Professor Grossman’s book titled Choose Your Medicine: Freedom of Therapeutic Choice in America. He has served as a member or legal consultant on three previous committees of the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine (formerly the Institute of Medicine). Professor Grossman earned his Ph.D. in History from Yale University, where he was awarded the George Washington Egleston Prize for Best Dissertation in the Field of American History. He received a J.D. magna cum laude from Harvard Law School and a B.A. summa cum laude from Yale University.
W. Craig Vanderwagen
W. Craig Vanderwagen, M.D.
President, East East Protection, LLC
Dr. Vanderwagen is a family physician who retired as a Rear Admiral in the United States Public Health Service in 2009. He served for 25 years in the Indian Health Service, the federal program of medical and public health services for American Indians and Alaska Natives. During this period he also served as the lead health official at a number of disasters including: medical care for Kosovar refugees (1999); advisor to the Afghan Ministry of Health (2002); director of public health and advisor to the Iraq Ministry of Health (2003-2004); the USNS Mercy response to the 2004 tsunami; and commander of the public health and medical response to Hurricanes Katrina/Rita. Dr. Vanderwagen’s last federal assignment (2006-9) was as the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services (DHHS). He was responsible for leading all federal public health and medical assets in disaster response and, responsibility for guiding the $11B DHHS medical countermeasure advanced development program to address CBRN threats which now has over 100 products in the development pipeline.
Dr. Vanderwagen is a Director and General Manager of East West Protection, a Potomac MD based firm specializing in public health and medical preparedness, detection, response, and command and control systems for CBRN threats and other disasters. He is Chairman of the Advisory Board of E-N-G Mobile Systems, a a design and construction firm specializing in mobile laboratories, clean room manufacturing, and public safety vehicles. He is Immediate Past Chairman of the Board at VIDO-Intervac, a Canadian vaccine research and development company. He is also a senior partner at Martin, Blanck, and Associates, a consulting firm of retired General and Flag officers specializing in military health matters. He is a frequent public speaker on biodefense, public health preparedness, and leadership.
He and his wife of 49 years, Suzanne, have three sons and 5 grandchildren and many extended family members with whom they spend much time.
Alastair J. Wood, MB C, FRCP
Alastair Wood, M.D.
Professor, Vanderbilt University School of Medicine
Dr. Wood was Professor of both Medicine and Pharmacology at Vanderbilt University Medical School and served as Assistant Vice Chancellor for Clinical Research and Associate Dean, Vanderbilt Medical School, before being appointed Emeritus Professor of Medicine and Emeritus Professor of Pharmacology in 2006.
He served as the Drug Therapy Section Editor of the New England Journal of Medicine from 1985 to 2004. He was a Partner at Symphony Capital LLC, a Private Equity Company investing in the clinical development of novel bio-pharmaceutical products from 2006-2018.
Dr. Wood has been honored by being elected to The National Academy of Medicine (formerly the IOM), The American Association of Physicians (AAP), The American Society for Clinical Investigation (ASCI), Honorary Fellow, American Gynecological and Obstetrical Society (AGOS), Fellowship of The American College of Physicians, Fellowship of The Royal College of Physicians of London, and Fellowship of The Royal College of Physicians of Edinburgh. He was the 2005 recipient of the Rawls-Palmer Award and in 2008 received the honorary degree of Doctor of Laws, honoris causa, from the University of Dundee. Dr. Wood has served on a number of Editorial Boards including the New England Journal of Medicine Editorial Board and his research has resulted in over 300 articles, reviews and editorials.
Marta Wosinska, Ph.D.
Deputy Director, Duke-Margolis Center for Health Policy
Marta E. Wosinska, PhD, is Consulting Professor and the Deputy Director for Policy at the Duke-Margolis Center for Health Policy. Widely recognized as an expert on health policy, economics, and regulation, Wosinska leads the Center’s Washington, DC office. In her role, she works with Duke-Margolis leadership on developing the Center’s strategy and then executes it with support of the roughly 30-person research team based in DC. Wosinska’s experience spans both academia as well as the executive and legislative branches of the federal government. In 2019, Wosinska served as an economic advisor to the US Senate Finance Committee, providing drug market analysis and expert guidance for the Committee’s bipartisan investigative and legislative work on drug pricing. Wosinska also served for over three years as Chief Healthcare Economist in the Office of Inspector General (OIG) at the US Department of Health and Human Services. Prior to OIG, Wosinska had a seven-year tenure at the US Food and Drug Administration (FDA) where she headed the Economics Staff at the Office of Strategic Programs in the Center for Drug Evaluation and Research and served as Senior Economic Advisor to FDA’s Deputy Commissioner for Medical Products and Tobacco, in both roles advising senior FDA leadership on a wide range of economic issues related to drugs and biologics.Before entering public service, Wosinska was an Assistant Professor of Marketing at the Harvard Business School, where her academic research focused on prescription drug marketing. She also was a visiting Assistant Professor at the Columbia Business School, where she developed and taught Healthcare Marketing and Marketing of Pharmaceuticals and Medical Devices. Wosinska received her PhD in economics from University of California at Berkeley and a bachelor’s degree from Arizona State University.
Matthew K. Wynia
Matthew K. Wynia, M.D., M.P.H
Director, Center for Bioethics and Humanities, University of Colorado
Dr. Wynia’s career has included developing a research institute and training programs focusing on bioethics, professionalism and policy issues (the AMA Institute for Ethics) and founding the AMA’s Center for Patient Safety. His research has focused on novel uses of survey data to inform and improve the practical management of ethical issues in health care and public policy. He has led projects on a wide variety of topics related to ethics and professionalism, including understanding and measuring the ethical climate of health care organizations and systems; ethics and quality improvement; communication, team-based care and engaging patients as members of the team; defining physician professionalism; public health and disaster ethics; medicine and the Holocaust (with the US Holocaust Memorial Museum); and inequities in health and health care. He has served on committees, expert panels and as a reviewer for the National Academies, The Joint Commission, the Hastings Center, the American Board of Medical Specialties, federal agencies, and other organizations. Dr. Wynia is the author of more than 160 published articles, chapters and essays, co-editor of several books, and co-author of a book on fairness in health care benefit design. His work has been published in JAMA, the New England Journal of Medicine, Annals of Internal Medicine, Health Affairs, and other leading medical and ethics journals, and he is a contributing editor for the American Journal of Bioethics. He has discussed his work as a guest on the BBC, ABC News, and National Public Radio, among others. Dr. Wynia is a past president of the American Society for Bioethics and Humanities (ASBH), and has chaired the Ethics Forum of the American Public Health Association (APHA) and the Ethics Committee of the Society for General Internal Medicine (SGIM).